Science Explorer Back to mapMap
Discussion
Researcher · Hebei Medical University · China

Yonghong Shi

Yonghong Shi publishes mostly in Molecular Biology, Immunology and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Mitochondrial Function and Pathology and Metabolism and Genetic Disorders.

ORCID 0000-0003-2266-7589 OpenAlex
World rank
#564,579
of 7,710,434 ranked researchers
Rank in China
#71,271
of 978,568
Works
187
Citations
6.8k
Citations per work
36.2
h-index
45
i10-index 110Top 5.1% in Molecular Biology
Yonghong Shi

What does Yonghong Shi research?

Yonghong Shi's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (11%), Immunology and Microbiology (7%).

Everything else: 104 works · 55.6% of their workLife Sciences: 62 works · 33.4% of their workBiochemistry, Genetics and Molecular Biology: 50 works · 26.5% of their workMolecular Biology: 43 works · 23.0% of their workClinical Biochemistry: 7 works · 3.5% of their workImmunology and Microbiology: 13 works · 6.9% of their workImmunology: 13 works · 6.9% of their workHealth Sciences: 21 works · 11.0% of their workMedicine: 21 works · 11.0% of their workGenetics: 9 works · 4.6% of their workNephrology: 6 works · 3.3% of their workEpidemiology: 6 works · 3.1% of their workTHEIR WORKYonghong Shi187works
Life Sciences33%Health Sciences11%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else10455.6%
    1. Biochemistry, Genetics and Molecular Biology5026.5%
    2. Immunology and Microbiology136.9%
    1. Medicine2111.0%
  1. 1Molecular Biology23% of their works
  2. 2Immunology7% of their works
  3. 3Genetics5% of their works
  4. 4Clinical Biochemistry4% of their works
  5. 5Nephrology3% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Yonghong Shi's research?

The keywords of their largest research topics: Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Mitochondria, Reactive Oxygen Species, Biochemical Genetics, Metabolic Disorders and Chronic Kidney Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Rituximab342 topics
  2. Chronic Lymphocytic Leukemia241 topic
  3. Genomic Aberrations241 topic
  4. Mitochondria231 topic
  5. Reactive Oxygen Species231 topic
  6. Biochemical Genetics121 topic
  7. Metabolic Disorders121 topic
  8. Chronic Kidney Disease111 topic
  9. Glomerular Filtration Rate111 topic
  10. Classification101 topic
  11. Lymphoma101 topic
  12. Arboviral Diseases81 topic
  13. Zika Virus81 topic
  14. DNA Damage71 topic
  15. RNA methylation71 topic
  16. Repair71 topic
  17. m6A-seq71 topic

Where does Yonghong Shi work?

Yonghong Shi's main affiliation in the publication record is Hebei Medical University, China.

How many publications and citations does Yonghong Shi have?

OpenAlex counts 187 works and 6,770 citations for Yonghong Shi, an h-index of 45, ranking #564,579 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Yonghong Shi

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Yonghong Shi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.